Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 15.7B | 13.7B | 14.0B | 18.3B |
Cost of revenue | 12.4B | 10.7B | 10.1B | 11.6B |
Gross profit | 3.3B | 3.0B | 3.9B | 6.8B |
Operating expense | ||||
Research & development | — | 840.5M | 1.4B | 1.5B |
Selling general and admin | 5.8B | 2.3B | 1.7B | 1.7B |
Other operating expenses | — | 1.3M | 207.2M | 120.5M |
Operating income | 3.3B | -6.7B | -2.5B | 694.6M |
Non operating interest income | ||||
Income | — | 130.7M | 75.7M | 67.1M |
Expense | — | 228.2M | 945.9M | 891.2M |
Other income expense | — | — | — | — |
Pretax income | -3.2B | -1.4B | -8.5B | 1.4B |
Tax provision | -628.1M | 4.2B | -1.8B | 66.5M |
Net income | -2.6B | -5.5B | -6.7B | 1.3B |
Basic EPS | -371.3 | — | -1.1K | 245.7 |
Diluted EPS | -371.3 | — | -1.1K | 245.7 |
Basic average shares | — | — | 6.2M | 6.2M |
Diluted average shares | — | — | 6.2M | 6.2M |
EBITDA | 3.3B | -4.6B | -2.9B | 2.5B |
Net income from continuing op. | — | -5.5B | -6.7B | 1.3B |
Minority interests | 280.4M | 160.3M | 191.6M | 223.3M |
Preferred stock dividends | — | — | — | — |